Application of EGFR/ERK/TRIM32 signal path in promoting differentiation of spinal nerve stem cells after spinal cord injury
A signal pathway, spinal cord injury technology, applied in the application field of promoting the differentiation of spinal cord neural stem cells after spinal cord injury, to achieve the effect of promoting functional recovery
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0050] Example 1 Discovery of EGFR / ERK / TRIM32 Signaling Pathway
[0051] 1. Myelin proteins inhibit the differentiation of neural stem cells into neurons by activating the EGFR-ERK pathway
[0052] Taking the neonatal mouse telencephalon neural stem cells 12 hours after birth of SD rats as the experimental object, add myelin protein (final concentration: 10 μg / mL) alone during the in vitro differentiation process, or add EGFR inhibitors respectively while adding myelin protein Gefitinib (final concentration 1μM), ERK inhibitor PD98059 (final concentration 1μM), Akt inhibitor MK2206 2HCl (final concentration 100nM), analyzed by immunofluorescence experiments, the results showed that myelin proteins activate EGFR / ERK signaling Pathways inhibit the differentiation of neural stem cells into neurons (such as figure 1 shown in a and b).
[0053] Taking the neonatal mouse telencephalon neural stem cells 12 hours after birth of SD rats as the experimental object, add myelin protein ...
Embodiment 2
[0057] Example 2 Application of EGFR / ERK / TRIM32 signaling pathway inhibitors in promoting the differentiation of spinal cord neural stem cells after spinal cord injury
[0058] Taking adult SD rats as the experimental subjects, after total spinal cord transection injury, the EGFR inhibitor Gefitinib (concentration of 1 μM, 9-10 μL, meeting the final concentration of 50 μM / kg) or the ERK inhibitor PD98059 (concentration of 1 μM , 3.6-4μL, to meet the final concentration of 20μM / kg), and then continuously intraperitoneally inject EGFR inhibitor Gefitinib (concentration of 30mg / mL, 450-500μL, to meet the final concentration of 75mg / kg) and ERK inhibitor PD98059 (concentration 20mg / mL, 90-100μL, meet the final concentration of 10mg / kg). According to the analysis of BBB score and tissue immunofluorescence staining experiment, the results showed that after total spinal cord transection injury, intraperitoneal injection of EGFR / ERK inhibitor can increase the expression of TRIM32 prot...
Embodiment 3
[0061] Example 3 Application of TRIM32 in promoting the differentiation of spinal cord neural stem cells after spinal cord injury
[0062] Taking the neonatal mouse telencephalon neural stem cells 12 hours after birth of SD rats as the experimental object, through lentivirus-mediated TRIM32 (the amino acid sequence is shown in SEQ ID NO.1, the nucleotide sequence of the coding gene is shown in SEQ ID NO.2 (shown) after overexpression in neural stem cells, set the myelin protein group and no myelin protein group, the results show that overexpression of TRIM32 protein in neural stem cells can antagonize the effect of myelin protein on neural stem cells' directed differentiation to neurons Inhibition, promote the differentiation of neural stem cells into neurons (such as figure 2 as shown in d).
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com